HKUMed Discovers Gut Bacterium Impairing Liver Cancer Immunotherapy, Advocating for Modulation Therapy to Enhance Efficacy
November 14, 2025
November 14, 2025
HONG KONG, Nov. 14 (TNSjou) -- The University of Hong Kong issued the following news release:
* * *
HKUMed discovers gut bacterium impairing liver cancer immunotherapy, advocating for modulation therapy to enhance efficacy
A research team led by the Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified a critical factor contributing to the failur . . .
* * *
HKUMed discovers gut bacterium impairing liver cancer immunotherapy, advocating for modulation therapy to enhance efficacy
A research team led by the Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified a critical factor contributing to the failur . . .
